Global Oral Cancer Treatment Market - 2023-2030

Market Overview

The Global Oral Cancer Treatment Market reached US$ 2.12 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 3.2 billion by 2030. The global oral cancer treatment market is expected to exhibit a CAGR of 6.1% during the forecast period (2023-2030). The increasing focus on personalized medicine, the rise of immunotherapy, and technological advancements in radiation therapy are some recent market trends.

The global oral cancer treatment market has been expanding continuously in recent years. Oral cancer is defined as the uncontrolled proliferation of malignant cells in the oral cavity, which includes the lips, tongue, cheeks, floor of the mouth, and throat.

The global oral cancer treatment market scope comprises components encompassing cancer types such as squamous cell carcinoma, verrucous carcinoma, minor salivary gland carcinomas, lymphomas, and others which have increased usage of oral cancer treatment market share. The global market for oral cancer treatment is expanding as a result of factors including the increasing prevalence of oral cancer, growing oral cancer awareness initiatives and early detection schemes.

Market Dynamics

Growing Aging Population to Drive the Growth of the Oral Cancer Treatment Market

The aging population is more susceptible to a variety of health problems, including oral cancer. With an aging population, there are more older patients with oral squamous cell carcinoma (OSCC). In 2020, there are expected to be 377,713 new cases of cancer of the lip and oral cavity, according to WHO 2023 revised estimates. Oral cancer is more common in men and older persons. Overall, the number of older people with mouth cancer is increasing, which is predicted to boost the demand for oral cancer treatment.

This is due to the growing geriatric population, for instance, according to World Health Organization (WHO) 2022 report, by 2030, about one out of every six people on the planet will be 60 or older. Within this time span, the share of the world population aged 60 and up is expected to increase from 1 billion in 2020 to 1.4 billion.

Increasing Awareness and Early Detection Programs is the Major Driver in the Global Oral Cancer Treatment Market

The growing awareness of oral cancer and the need for early identification has resulted in the implementation of screening programs and awareness campaigns. These activities aid in the early detection of oral cancer cases, resulting in timely intervention and improved treatment outcomes.

For instance, on 24 january 2023, Biocon Foundation, Biocon Limited's CSR branch, was recognized for its 'Oral Cancer Screening Programme' at the annual IHW Summit & Awards in Mumbai. The India Health and Wellness (IHW) Council awarded the program the prestigious Gold Award in the area of "Disease Screening Initiative of the Year. Thus, increasing awareness about the oral cancer will drive the market over the forecast period.

The Side Effects of Treatment will Hamper the Growth of the Market.

Oral cancer treatment techniques such as radiation therapy and chemotherapy, may cause side effects such as mucositis, xerostomia, and dysphagia. These side effects have an influence on patients' quality of life and may necessitate supportive care treatments. Radiation-induced mucositis affects up to 91% of patients with head and neck cancer who get radiation. Considering these factors, the side effects associated with treatment can limit the oral cancer treatment market growth.

COVID-19 Impact Analysis

The financial health of companies across all industries has been impacted by the COVID-19 pandemic and lockdown in numerous nations throughout the world. Therefore, for the period of the COVID-19 public health emergency, the U.S. Food and Drug Administration (FDA) issued guidelines that include general considerations to aid sponsors and researchers, ensuring the safety of trial participants, adhering to good clinical practice (GCP), and minimizing risks to trial integrity.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict has had significant impacts on the global market for oral cancer treatment. It has disrupted healthcare infrastructure, hampered treatment access in afflicted areas, caused economic instability, disrupted international cooperation, and altered market dynamics.

Damaged healthcare facilities, restricted mobility, financial constraints, delayed diagnosis, and hampered research and development activities are among the repercussions of the conflict. These factors affect the availability and quality of oral cancer therapy collectively, illustrating the war's far-reaching repercussions for healthcare systems and patient outcomes.

Segment Analysis

The global oral cancer treatment market is segmented based on type, treatment, distribution channel, and region.

The Squamous Cell Carcinoma Segment Accounts for 31.2% of Market Share Owing to Rising Prevalence.

The Squamous Cell Carcinoma (SCC) segment is poised to dominate the global oral cancer treatment market due to its high prevalence and well-established treatment approaches. SCC, the most common kind of oral cancer, receives major research and development attention, resulting in breakthroughs in detection and treatment options.

Squamous cell carcinoma (SCC) is a type of cancer that begins in the squamous cells. These are the skin-like flat cells that line the insides of the mouth, nose, larynx, and throat. Cancer is referred to as a carcinoma. SCC accounts for more than 90 percent of all mouth and oropharyngeal cancers. However, there is rising concern about the development of resistance to present oral squamous cell carcinoma (OSCC) treatment options. As a result, there is an urgent need for novel, effective treatments to address this issue and enhance patient outcomes in OSCC.

For instance, scientists from Tokyo Medical and Dental University (TMDU) discovered a remarkable discovery in Molecular Therapy Oncolytics in 2022. They found that miR-634 could significantly reduce cisplatin resistance in oral squamous cell carcinoma (OSCC) cells, resulting in increased tumor cell eradication. When an ointment containing miR-634 was put topically on mice, the outcomes were equivalent. This shows that this simple topical treatment may improve the prognosis of people with advanced oral cancer. Thus driving the segment growth over the forecast period.

Geographical Analysis

North America Accounted for Approximately 36.4% of the Market Share Owing to the Increasing Prevalence of Oral Cancer

North America is expected to dominate the global oral cancer treatment market due to the increasing prevalence of oral cancer in the region. The prevalence of risk factors is increasing, which is a result of variables like lifestyle choices. The sophisticated healthcare system in North America, which includes specialized cancer treatment facilities, knowledgeable medical staff, and a focus on research and development, permits accurate cancer diagnosis and treatment.

For instance, according to American Society of Clinical Oncology (ASCO) report of 2023, in the United States, about 54,540 persons are expected to be diagnosed with oral or oropharyngeal cancer, with men accounting for 39,290 cases and women accounting for 15,250 cases in 2023. The number of people diagnosed with oral or oropharyngeal cancer worldwide in 2020 is expected to reach 476,125. Notably, men had more than double the incidence rates of these malignancies as women, indicating a major gender discrepancy in the frequency of these diseases.

Competitive Landscape

The major global players in the oral cancer treatment market include: Novartis AG, Hospira, Inc., Teva Pharmaceutical Industries Ltd, Pfizer Inc., Lilly USA, LLC, Merck & Co., Inc., Fresenius Kabi AG, Accord BioPharma, Inc. Bristol-Myers Squibb Company, and Spectrum Pharmaceuticals, Inc., among others.

Why Purchase the Report?

• To visualize the global oral cancer treatment market segmentation based on type, treatment, distribution channel, and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of oral cancer treatment market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping is available in Excel consisting of key products of all the major players.

The global oral cancer treatment market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies